Published in Med Phys on March 17, 1994
Bridging the gap between IMRT and VMAT: dense angularly sampled and sparse intensity modulated radiation therapy. Med Phys (2011) 2.18
Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol (2011) 2.05
Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys (2007) 1.91
Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of Western South Dakota: initial observations and results. Cancer Control (2008) 1.85
18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med (2009) 1.53
Comparing radiation treatments using intensity-modulated beams, multiple arcs, and single arcs. Int J Radiat Oncol Biol Phys (2010) 1.25
Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. Phys Med Biol (2008) 1.23
Dosimetric comparison of helical tomotherapy and Gamma Knife stereotactic radiosurgery for single brain metastasis. Radiat Oncol (2006) 1.10
RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison. Radiat Oncol (2013) 1.08
Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study. Phys Med Biol (2007) 1.06
On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function. Phys Med Biol (2009) 1.04
The number of beams in IMRT--theoretical investigations and implications for single-arc IMRT. Phys Med Biol (2010) 1.03
On the impact of longitudinal breathing motion randomness for tomotherapy delivery. Phys Med Biol (2008) 1.03
Modality comparison for small animal radiotherapy: a simulation study. Med Phys (2014) 1.00
Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer. BMC Cancer (2011) 0.98
Radiation oncology in the era of precision medicine. Nat Rev Cancer (2016) 0.97
Magnetic resonance imaging for adaptive cobalt tomotherapy: A proposal. J Med Phys (2006) 0.97
Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma. J Cancer Res Clin Oncol (2014) 0.94
Predictive factors for radiation pneumonitis in lung cancer treated with helical tomotherapy. Cancer Res Treat (2013) 0.93
A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol (2010) 0.93
The impact of linac output variations on dose distributions in helical tomotherapy. Phys Med Biol (2007) 0.93
Use of tomotherapy in treatment of synchronous bilateral breast cancer: dosimetric comparison study. Br J Radiol (2015) 0.91
On the making of sharp longitudinal dose profiles with helical tomotherapy. Phys Med Biol (2007) 0.91
Tomotherapy archive structure and new software tool for loading and advanced analysis of data contained in it. Rep Pract Oncol Radiother (2011) 0.91
Evolution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC). Radiat Oncol (2009) 0.91
Quality Control of Portal Imaging with PTW EPID QC PHANTOM. Strahlenther Onkol (2009) 0.91
Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode. Radiat Oncol (2013) 0.90
The optimal selection of radiotherapy treatment for hepatocellular carcinoma. Gut Liver (2012) 0.90
Treatment outcomes of helical intensity-modulated radiotherapy for unresectable hepatocellular carcinoma. Gut Liver (2013) 0.90
Immediate reconstruction with an expander/implant following ablatio mammae because of breast cancer : side effects and cosmetic results after adjuvant chest wall radiotherapy. Strahlenther Onkol (2009) 0.90
Tomotherapy as a tool in image-guided radiation therapy (IGRT): theoretical and technological aspects. Biomed Imaging Interv J (2007) 0.89
Image-guided Radiotherapy Of Esophageal Cancer By Helical Tomotherapy: Acute Toxicity And Preliminary Clinical Outcome. J Thorac Dis (2009) 0.89
Comparison of survival rates between patients treated with conventional radiotherapy and helical tomotherapy for head and neck cancer. Radiat Oncol J (2013) 0.88
Breathing-synchronized delivery: a potential four-dimensional tomotherapy treatment technique. Int J Radiat Oncol Biol Phys (2007) 0.88
Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer. World J Gastroenterol (2009) 0.88
Accelerated large volume irradiation with dynamic Jaw/Dynamic Couch Helical Tomotherapy. Radiat Oncol (2012) 0.87
Is helical tomotherapy accurate and safe enough for spine stereotactic body radiotherapy? J Cancer Res Clin Oncol (2012) 0.87
Clinical analysis of intracranial germinoma's craniospinal irradiation using helical tomotherapy. Chin J Cancer Res (2014) 0.87
Image-guided radiotherapy: a new dimension in radiation oncology. Dtsch Arztebl Int (2011) 0.86
From analytic inversion to contemporary IMRT optimization: radiation therapy planning revisited from a mathematical perspective. Phys Med (2011) 0.85
Helical and Static-port Tomotherapy Using the Newly-developed Dynamic Jaws Technology for Lung Cancer. Technol Cancer Res Treat (2014) 0.85
Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study. BMC Cancer (2011) 0.85
Helical tomotherapy in children and adolescents: dosimetric comparisons, opportunities and issues. Cancers (Basel) (2011) 0.85
Intensity modulated radiotherapy: advantages, limitations and future developments. Biomed Imaging Interv J (2006) 0.84
A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion management. Phys Med Biol (2010) 0.84
The potential of helical tomotherapy in the treatment of head and neck cancer. Oncologist (2013) 0.84
Quasi-IMAT technique and secondary cancer risk in prostate cancer. Strahlenther Onkol (2009) 0.84
Simultaneous irradiation of the breast and regional lymph nodes in prone position using helical tomotherapy. Br J Radiol (2012) 0.83
Tomotherapy radiosurgery for arteriovenous malformations--current possibilities and future options with helical tomotherapy dynamic jaws? Technol Cancer Res Treat (2013) 0.83
Task Group 76 Report on 'The management of respiratory motion in radiation oncology' [Med. Phys. 33, 3874-3900 (2006)]. Med Phys (2009) 0.83
A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer. Gut Liver (2016) 0.82
Empirical estimation of beam-on time for prostate cancer patients treated on Tomotherapy. Rep Pract Oncol Radiother (2013) 0.82
Prospective study on dosimetric comparison of helical tomotherapy and 3DCRT for craniospinal irradiation - A single institution experience. Rep Pract Oncol Radiother (2015) 0.82
Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes. Biomed Res Int (2014) 0.81
Surface dose in the treatment of breast cancer with helical tomotherapy. Strahlenther Onkol (2009) 0.80
Megavoltage CT imaging quality improvement on TomoTherapy via tensor framelet. Med Phys (2013) 0.80
Clinical outcomes of helical tomotherapy for super-elderly patients with localized and locally advanced prostate cancer: comparison with patients under 80 years of age. J Radiat Res (2015) 0.79
Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy. ACS Nano (2016) 0.79
Feasibility of concurrent treatment with the scanning ultrasound reflector linear array system (SURLAS) and the helical tomotherapy system. Int J Hyperthermia (2008) 0.79
An attempted substitute study of total skin electron therapy technique by using helical photon tomotherapy with helical irradiation of the total skin treatment: a phantom result. Biomed Res Int (2013) 0.79
Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer. A comparative plan analysis. Strahlenther Onkol (2012) 0.79
Helical tomotherapy: an innovative radiotherapy technique for the treatment of locally advanced oropharynx and inoperable oral cavity carcinoma. Radiat Oncol (2013) 0.79
Emission guided radiation therapy for lung and prostate cancers: a feasibility study on a digital patient. Med Phys (2012) 0.79
The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer. Transl Lung Cancer Res (2015) 0.79
Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy. Int J Radiat Oncol Biol Phys (2013) 0.78
Feasibility of intrafraction whole-body motion tracking for total marrow irradiation. J Biomed Opt (2011) 0.78
Treatment planning to improve delivery accuracy and patient throughput in helical tomotherapy. Int J Radiat Oncol Biol Phys (2009) 0.78
Impact of very long time output variation in the treatment of total marrow irradiation with helical tomotherapy. Radiat Oncol (2013) 0.77
Optimization approaches to volumetric modulated arc therapy planning. Med Phys (2015) 0.77
Commissioning experience and quality assurance of helical tomotherapy machines. J Med Phys (2009) 0.77
Dosimetric differences in flattened and flattening filter-free beam treatment plans. J Med Phys (2016) 0.77
Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation. Int J Radiat Oncol Biol Phys (2014) 0.77
Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen. BMC Cancer (2013) 0.76
Verification of tomotherapy dose delivery. J Med Phys (2009) 0.75
Quality assurance of TomoDirect treatment plans using I'mRT MatriXX. Biomed Imaging Interv J (2012) 0.75
Fan-beam intensity modulated proton therapy. Med Phys (2013) 0.75
Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment. Radiat Oncol (2014) 0.75
Novel, full 3D scintillation dosimetry using a static plenoptic camera. Med Phys (2014) 0.75
Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays. J Radiat Res (2015) 0.75
Initial experience in treating lung cancer with helical tomotherapy. Biomed Imaging Interv J (2007) 0.75
Investigation of probabilistic optimization for tomotherapy. J Appl Clin Med Phys (2012) 0.75
Dosimetry of interface region near closed air cavities for Co-60, 6 MV and 15 MV photon beams using Monte Carlo simulations. J Med Phys (2010) 0.75
Practical and clinical considerations in Cobalt-60 tomotherapy. J Med Phys (2009) 0.75
Fast Megavoltage Computed Tomography: A Rapid Imaging Method for Total Body or Marrow Irradiation in Helical Tomotherapy. Int J Radiat Oncol Biol Phys (2016) 0.75
Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls. Onco Targets Ther (2016) 0.75
Application of helical tomotherapy for two cases of advanced hepatocellular carcinoma. Korean J Intern Med (2011) 0.75
Rapid Automated Target Segmentation and Tracking on 4D Data without Initial Contours. Radiol Res Pract (2014) 0.75
Advantage of 3D volumetric dosemeter in delivery quality assurance of dynamic arc therapy: comparison of pencil beam and Monte Carlo calculations. Br J Radiol (2013) 0.75
Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study. World J Radiol (2013) 0.75
Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy. Radiat Oncol (2014) 0.75
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy. J Vis Exp (2015) 0.75
Task-driven imaging in cone-beam computed tomography. Proc SPIE Int Soc Opt Eng (2015) 0.75
The role of Cobalt-60 in modern radiation therapy: Dose delivery and image guidance. J Med Phys (2009) 0.75
[Development of methods and instruments for radiation therapy. The most important developments from the viewpoint of a physicist]. Strahlenther Onkol (2012) 0.75
The Impact of the Grid Size on TomoTherapy for Prostate Cancer. J Med Phys (2017) 0.75
Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell (1996) 16.73
Ecological degradation in protected areas: the case of Wolong Nature Reserve for giant pandas. Science (2001) 6.52
A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet (1999) 4.96
A fixative for intestinal parasites permitting the use of concentration and permanent staining procedures. Am J Clin Pathol (1977) 4.58
Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol (1998) 4.17
Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry (2011) 4.16
Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci U S A (1993) 4.05
Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics (2012) 3.97
Glutamate release promotes growth of malignant gliomas. Nat Med (2001) 3.67
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest (2000) 3.57
High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res (1998) 3.56
Signaling and transcription in T helper development. Annu Rev Immunol (2000) 3.44
Ca2+ channel selectivity at a single locus for high-affinity Ca2+ interactions. Neuron (1995) 3.39
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit (2009) 3.32
A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem (2000) 3.26
Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1). J Biol Chem (1994) 3.09
Induction of apoptosis by the low-affinity NGF receptor. Science (1993) 3.04
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys (2001) 2.85
Rhabdomyosarcoma. A new classification scheme related to prognosis. Arch Pathol Lab Med (1992) 2.79
Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75
Retrohoming of a bacterial group II intron: mobility via complete reverse splicing, independent of homologous DNA recombination. Cell (1998) 2.74
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. J Virol (1999) 2.69
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 2.64
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 2.52
Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res (1998) 2.49
MicroRT-small animal conformal irradiator. Med Phys (2007) 2.46
Observation of the spin-Seebeck effect in a ferromagnetic semiconductor. Nat Mater (2010) 2.44
PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta (2004) 2.43
A group II intron RNA is a catalytic component of a DNA endonuclease involved in intron mobility. Cell (1995) 2.37
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8. Oncogene (2010) 2.37
Primary structure and expression of a sodium channel characteristic of denervated and immature rat skeletal muscle. Neuron (1990) 2.23
Evaluation of unpreserved and preserved stools for the detection and identification of intestinal parasites. Am J Clin Pathol (1974) 2.23
Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J (1996) 2.22
Identification of a titratable lysine residue that determines sensitivity of kidney potassium channels (ROMK) to intracellular pH. EMBO J (1996) 2.21
Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia (2009) 2.18
Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol (2012) 2.18
Tomotherapy. Semin Radiat Oncol (1999) 2.16
Sustained growth and three-dimensional organization of primary mammary tumor epithelial cells embedded in collagen gels. Proc Natl Acad Sci U S A (1979) 2.15
Functional domains of the Rsp5 ubiquitin-protein ligase. Mol Cell Biol (1999) 2.15
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem (1995) 2.15
Cell separation by dielectrophoretic field-flow-fractionation. Anal Chem (2000) 2.13
MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc Natl Acad Sci U S A (2000) 2.12
Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci U S A (1995) 2.09
Regulation of proprioceptive memory by subarachnoid regional anesthesia. Anesthesiology (2000) 2.08
Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J Virol (2000) 2.08
Prediction of linear B-cell epitopes using amino acid pair antigenicity scale. Amino Acids (2007) 2.06
Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell (1999) 2.04
The removal of human breast cancer cells from hematopoietic CD34+ stem cells by dielectrophoretic field-flow-fractionation. J Hematother Stem Cell Res (1999) 2.03
Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice. J Thromb Haemost (2007) 2.00
Progress in high resolution atomic force microscopy in biology. Q Rev Biophys (1995) 1.99
Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem (2001) 1.98
Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res (1995) 1.97
Characteristics of the in vitro assay of murine sarcoma virus (Moloney) and virus-infected cells. J Natl Cancer Inst (1968) 1.95
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol (2000) 1.94
Mobility of yeast mitochondrial group II introns: engineering a new site specificity and retrohoming via full reverse splicing. Cell (1997) 1.91
Architecture of a K+ channel inner pore revealed by stoichiometric covalent modification. Neuron (1999) 1.90
Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol (1985) 1.87
Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86
Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum (2001) 1.84
Cloning and expression of N-acetylglucosaminyltransferase I, the medial Golgi transferase that initiates complex N-linked carbohydrate formation. Proc Natl Acad Sci U S A (1990) 1.81
Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J (2004) 1.79
Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem (1994) 1.76
Probing ion permeation and gating in a K+ channel with backbone mutations in the selectivity filter. Nat Neurosci (2001) 1.76
A survey of the prevalence of Giardia in dogs presented to Canadian veterinary practices. Can Vet J (2001) 1.75
The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet (1999) 1.75
Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL. Mol Cell Biol (2001) 1.73
Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol (2001) 1.72
Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. Circulation (1999) 1.69
Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest (2001) 1.66
The origin of intermediary metabolism. Proc Natl Acad Sci U S A (2000) 1.66
Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta (1998) 1.65
Sustained growth in primary culture of normal mammary epithelial cells embedded in collagen gels. Proc Natl Acad Sci U S A (1980) 1.65
Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am J Transplant (2012) 1.61
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis (2006) 1.60
Nuclear import of Cdk/cyclin complexes: identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1. J Cell Biol (1999) 1.60
Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest (1983) 1.59
N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation (1995) 1.58
Intestinal parasites in metropolitan Toronto day-care centres. Can Med Assoc J (1984) 1.58
Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci (1997) 1.57
An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet (1999) 1.56
Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration. J Invest Dermatol (2000) 1.56
Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A (1999) 1.56
Functionalization of carbon nanotubes by electrochemical reduction of aryl diazonium salts: a bucky paper electrode. J Am Chem Soc (2001) 1.56
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene (2012) 1.55
The evolving portrait of cancer metastasis. Cold Spring Harb Symp Quant Biol (2005) 1.55
A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2001) 1.54
Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching. Proc Natl Acad Sci U S A (1999) 1.53
Common SNPs explain some of the variation in the personality dimensions of neuroticism and extraversion. Transl Psychiatry (2012) 1.52
Polymer-supported bilayer on a solid substrate. Biophys J (1992) 1.50
Increased phonon scattering by nanograins and point defects in nanostructured silicon with a low concentration of germanium. Phys Rev Lett (2009) 1.50
Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. Methods Enzymol (1999) 1.50
Dientamoeba fragilis: a review with notes on its epidemiology, pathogenicity, mode of transmission, and diagnosis. Am J Trop Med Hyg (1977) 1.50
Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50
P-Selectin glycoprotein ligand 1 (PSGL-1) is a physiological ligand for E-selectin in mediating T helper 1 lymphocyte migration. J Exp Med (2000) 1.50
Molecular and genetic analyses of the Caenorhabditis elegans dpy-2 and dpy-10 collagen genes: a variety of molecular alterations affect organismal morphology. Mol Biol Cell (1993) 1.49
Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Chin Med J (Engl) (1999) 1.48
Human blood-brain barrier insulin receptor. J Neurochem (1985) 1.47
Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression. J Virol (1999) 1.47